Baker Tilly Wealth Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Baker Tilly Wealth Management's AMGN Position: Q3 2026 in Review
Baker Tilly Wealth Management increased its Amgen (AMGN) stake by 0.07% in Q3 2026, buying an estimated $399 and bringing the position to 1,485 shares worth $626K. The position accounts for 0.12% of the portfolio, ranked #141.
Baker Tilly Wealth Management first reported a position in AMGN in Q4 2020 and has held it in 24 quarters since. The position peaked at $1.6M in Q4 2022. 2,162 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Baker Tilly Wealth Management held 1,485 shares of Amgen worth $626K as of Q3 2026.
- Baker Tilly Wealth Management bought 1 Amgen share in Q3 2026, an estimated $399.
- Amgen made up 0.12% of Baker Tilly Wealth Management's portfolio in Q3 2026, its #141 holding.
- Baker Tilly Wealth Management first reported a position in Amgen in Q4 2020 and has held it in 24 quarters since.
- Baker Tilly Wealth Management's Amgen position peaked at $1.6M in Q4 2022.
- 2,162 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Baker Tilly Wealth Management's 13F filing for Q3 2026, filed 5 Oct 2026.